IT1248060B - Eparine acilate come inibitori della replicazione di retrovirus - Google Patents

Eparine acilate come inibitori della replicazione di retrovirus

Info

Publication number
IT1248060B
IT1248060B ITMI911644A ITMI911644A IT1248060B IT 1248060 B IT1248060 B IT 1248060B IT MI911644 A ITMI911644 A IT MI911644A IT MI911644 A ITMI911644 A IT MI911644A IT 1248060 B IT1248060 B IT 1248060B
Authority
IT
Italy
Prior art keywords
heparins
acilated
inhibitors
retrovirus replication
retrovirus
Prior art date
Application number
ITMI911644A
Other languages
English (en)
Inventor
Ida Caramazza
Giorgio Zoppetti
Daniela Modena
Antonio G Siccardi
Alberto Beretta
Lucia Lopalco
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of ITMI911644A0 publication Critical patent/ITMI911644A0/it
Priority to ITMI911644A priority Critical patent/IT1248060B/it
Priority to AT92911535T priority patent/ATE147411T1/de
Priority to HU9303531A priority patent/HUT65741A/hu
Priority to JP4510438A priority patent/JPH06511265A/ja
Priority to CA002111231A priority patent/CA2111231A1/en
Priority to PCT/EP1992/001261 priority patent/WO1992022588A1/en
Priority to DE69216610T priority patent/DE69216610D1/de
Priority to EP92911535A priority patent/EP0588855B1/en
Priority to AU19209/92A priority patent/AU1920992A/en
Publication of ITMI911644A1 publication Critical patent/ITMI911644A1/it
Priority to NO934528A priority patent/NO934528L/no
Application granted granted Critical
Publication of IT1248060B publication Critical patent/IT1248060B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Eparine N-acilate con acidi mono- o di- carbossilici presentano attività di inibizione della replicazione di retrovirus, in particolare di HIV.
ITMI911644A 1991-06-14 1991-06-14 Eparine acilate come inibitori della replicazione di retrovirus IT1248060B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI911644A IT1248060B (it) 1991-06-14 1991-06-14 Eparine acilate come inibitori della replicazione di retrovirus
CA002111231A CA2111231A1 (en) 1991-06-14 1992-06-05 Acylated heparins as inhibitors of the replication of retroviruses
HU9303531A HUT65741A (en) 1991-06-14 1992-06-05 Process for producing acylated heparins, with effect in inhibition the replication of retroviruses and pharmaceutical compositions containing them as active agents
JP4510438A JPH06511265A (ja) 1991-06-14 1992-06-05 レトロウィルス複製抑制剤としてのアシル化ヘパリン
AT92911535T ATE147411T1 (de) 1991-06-14 1992-06-05 Acylierte heparine als inhibitoren der replikation von retroviren
PCT/EP1992/001261 WO1992022588A1 (en) 1991-06-14 1992-06-05 Acylated heparins as inhibitors of the replication of retroviruses
DE69216610T DE69216610D1 (de) 1991-06-14 1992-06-05 Acylierte Heparine als Inhibitoren der Replikation von Retroviren
EP92911535A EP0588855B1 (en) 1991-06-14 1992-06-05 Acylated heparins as inhibitors of the replication of retroviruses
AU19209/92A AU1920992A (en) 1991-06-14 1992-06-05 Acylated heparins as inhibitors of the replication of retroviruses
NO934528A NO934528L (no) 1991-06-14 1993-12-10 Acylerte hepariner som inhibitorer for replikasjonen av retrovirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911644A IT1248060B (it) 1991-06-14 1991-06-14 Eparine acilate come inibitori della replicazione di retrovirus

Publications (3)

Publication Number Publication Date
ITMI911644A0 ITMI911644A0 (it) 1991-06-14
ITMI911644A1 ITMI911644A1 (it) 1992-12-14
IT1248060B true IT1248060B (it) 1995-01-05

Family

ID=11360123

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911644A IT1248060B (it) 1991-06-14 1991-06-14 Eparine acilate come inibitori della replicazione di retrovirus

Country Status (10)

Country Link
EP (1) EP0588855B1 (it)
JP (1) JPH06511265A (it)
AT (1) ATE147411T1 (it)
AU (1) AU1920992A (it)
CA (1) CA2111231A1 (it)
DE (1) DE69216610D1 (it)
HU (1) HUT65741A (it)
IT (1) IT1248060B (it)
NO (1) NO934528L (it)
WO (1) WO1992022588A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118816A (en) * 1962-04-03 1964-01-21 Abbott Lab N-succinyl heparin and process
EP0293826A3 (en) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
AU4426289A (en) * 1988-10-05 1990-05-01 Nicola Diferrante Methods for interfering with hiv multiplication and composition for the treatment of aids

Also Published As

Publication number Publication date
NO934528D0 (no) 1993-12-10
EP0588855A1 (en) 1994-03-30
CA2111231A1 (en) 1992-12-23
JPH06511265A (ja) 1994-12-15
NO934528L (no) 1994-02-10
ITMI911644A1 (it) 1992-12-14
EP0588855B1 (en) 1997-01-08
HUT65741A (en) 1994-07-28
WO1992022588A1 (en) 1992-12-23
ITMI911644A0 (it) 1991-06-14
AU1920992A (en) 1993-01-12
DE69216610D1 (de) 1997-02-20
ATE147411T1 (de) 1997-01-15

Similar Documents

Publication Publication Date Title
ATE116857T1 (de) Oligodesoxynukleotide als inhibitoren der replikation von retroviren und der expression von onkogenen.
ES2135347B1 (es) Hidroxifeniltriazinas.
ATE296624T1 (de) Retrovirusprotease inhibitoren
KR950700323A (ko) 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE)
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
CY1105068T1 (el) ΈΝΑ ΠΡΟΪΟΝ ΣΥΝΔΥΑΣΜΟΥ ΠΟΥ ΠEPΙΛΑΜΒΑΝΕΙ ΜΕΛΑΓΑΤΡΑΝΗ ΚΑΙ ΕΝΑΝ ΑΝΑΣΤΟΛΕΑ ΠΑΡΑΓΟΝΤΑ ΓΙΑ Xa
IS2216B (is) Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
DE69034070T2 (de) Racemisches Huperzin A
ES2051675T3 (es) Inhibidores de protorfirinogeno y su uso en composiciones para detectar y tratar tumores.
EA200200596A1 (ru) Окс (ади) азолилгидроксамовые кислоты, полезные в качестве ингибиторов проколлаген-с-протеиназы
ES2138595T3 (es) Inhibidores de citoquinas.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
IT1248060B (it) Eparine acilate come inibitori della replicazione di retrovirus
EA199800200A1 (ru) Ингибиторы пролилэндопептидазы
FI950842A0 (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
ES2155091T3 (es) Procedimiento para la produccion de inhibidores de la proteasa del vih.
DK0570414T3 (da) Naphthoquinonderivater til behandling af kronisk inflammation
EA199900579A1 (ru) Применение ингибиторов комт для производства лекарственного средства для профилактики сосудистых дисфункций при диабете
ES2070103T1 (es) Ciclobutenodionas derivadas de triptaminas contra las migrañas.
ES2059106T3 (es) Solucion de infusion de mitonafide.
SU1631950A1 (ru) N,n-диметил-n-(4-окси-3,5-ди-трет-бутилбензил)-аммоний хлорид в качестве ингибитора термополимеризации мономеров
ES2080854T3 (es) Uso hipotrigliceridemico de ciertos bis(3,5-di-alquil-4-hidroxifeniltio)metanos.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960627